Onto Innovation sees 25%+ revenue growth in second half Onto Innovation delivered an outstanding quarter with revenue, gross margin, operating margin, and earnings per share exceeding guidance. The company's backlog has surpassed $1.1B. Onto Innovation's strong p
Earnings Call Insights: Exzeo Group (XZO) Q2 2026 Management view - âExzeo continues down the path of strong execution and attractive financial results.â (Chief Financial Officer Suela Bulku) She highlighted âmanaged premium on the platform remains robust at $1.4 billion,â âa...<
The mobile office provider raised its full-year revenue forecast, citing higher activation volumes and a robust order book. WillScot revised its 2026 revenue guidance to approximately $2.3 billion, up from prior expectations, driven by strong demand for large projects. Net
Halozyme projects $8.65-$9.00 non-GAAP EPS for 2026 Halozyme Therapeutics has raised its revenue outlook to $1.835B-$1.91B for 2026. The company's Q2 2026 management view highlighted ENHANZE royalty revenue growth and new deal momentum. The revenue growth is attr
Tripadvisor projects Q3 experiences revenue growth of 5% to 7% while finalizing the $700 million sale of TheFork. Tripadvisor expects Q3 experiences booked revenue to rise 5% to 7%, aligning with management guidance during its Q2 2026 earnings call. The company reported Q2
The company projects non-GAAP EPS of $4.83-$5.03 for Q3 2026 after reporting strong Q2 results. Arrow Electronics guided Q3 2026 sales in a range of $9.6 billion to $10.2 billion, with non-GAAP earnings per share of $4.83 to $5.03. The outlook follows a robust Q2 performan
The healthcare services provider revised its full-year guidance upward after strong Q2 2026 performance. Pennant Group raised its 2026 revenue forecast to a range of $1.17 billion to $1.19 billion, up from prior guidance. The company also increased its earnings per share o
The company reports Q1 revenue of $90 million, up 30% year-over-year, driven by strong Grid segment performance. American Superconductor Corporation (AMSC) projected Q2 fiscal 2026 revenue above $85 million as it scales production capacity in Brazil. The company reported Q
CarParts.com targets free cash flow positive in 2026 CarParts.com is targeting to be free cash flow positive in 2026, driven by its A-Premium near $50M run rate. The company achieved its highest adjusted EBITDA since the third quarter of 2023, with $1.8 million in Q2
Immunocore plans to unveil TEBE-AM trial data by year-end 2026 while scaling KIMMTRAK to over 1,000 patients annually. Immunocore Holdings (IMCR) outlined plans to release early TEBE-AM clinical data by the end of 2026, as the company focuses on expanding its oncology and
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.